Aldrin Pharma

Marketing of healthcare products, including tablets, syrups, and ointments, by Aldrin Pharma in India.

About Aldrin Pharma

Aldrin Pharma is a Healthcare company. It operates as a marketing of healthcare products, including tablets, syrups, and ointments, by Aldrin Pharma in India. The company has 16 employees. Its Indian entity Aldrin Pharma Private Limited reported revenue of β‚Ή3.91 Cr. Aldrin Pharma offers products and services including Tablets/Capsules and Syrup. Its focus areas include Research and Development, Drug Innovation, Product Formulation and Pharmaceuticals.

Company details

Aldrin Pharma Private Limited was incorporated on 7 April 2017 under the Companies Act 1956 and is recognized as a growing Indian healthcare company. A wide range of products, such as tablets, capsules, syrups, ointments, lotions, suspensions, and sachets, are marketed by the company to cater to various healthcare needs. Emphasis is placed on quality assurance, incorporation of latest research, and achievement of customer satisfaction through diverse business verticals. Contact information and testimonials indicate reliable operations from its base in Navi Mumbai.

  • Employees 16
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Aldrin Pharma Private Limited
  • Date of Incorporation 07 Apr, 2017
  • Jurisdiction Ahmednagar, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹3.91 Cr

    FY 2024 · +40% YoY

  • Net Profit
    ₹5.6 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹12.9 Lakh

    FY 2024 · 3% margin

  • Employee Count
    16

Products & Services of Aldrin Pharma

Aldrin Pharma offers a comprehensive portfolio of products and services, including Tablets/Capsules and Syrup.

Tablets/Capsules
Pharmaceutical Products

Tablets and capsules are utilized as common forms of medication for ease of use and precise dosing in healthcare applications.

Syrup
Pharmaceutical Products

Syrups are employed as liquid medications that are often administered to pediatric patients for their palatability and ease of use.

Board of directors of Aldrin Pharma Private Limited (Aldrin Pharma)

Aldrin Pharma Private Limited is the primary company behind Aldrin Pharma. The board of Aldrin Pharma Private Limited currently have 4 directors; the longest-serving is Vasant Govind Gawate, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Vasant Govind Gawate
DIN 07775660
Director07 Apr 20179 yrs 6 moAldrin Pharma Private Limited
Neeta Santosh Adsul
DIN 07774461
Director07 Apr 20179 yrs 6 moAldrin Pharma Private Limited
Sonal Sandip Tambe
DIN 07775705
Director07 Apr 20179 yrs 6 moAldrin Pharma Private Limited
Surekha Nitin Bankar
DIN 09318210
Director13 Sep 20215 yrs 1 moAldrin Pharma Private Limited

Financials of Aldrin Pharma

Figures of Aldrin Pharma Private Limited, the primary company behind Aldrin Pharma, for FY 2024. Revenue was ₹3.91 Cr (+40% year on year). Net profit was ₹5.6 Lakh (1% margin). EBITDA was ₹12.9 Lakh (3% margin). Revenue has grown at a compounded annual rate of +51% over three years and +49% over five years.

  • ₹3.91 CrRevenue · FY 2024 · +40% YoY
  • ₹5.6 LakhNet profit · 1% margin
  • ₹12.9 LakhEBITDA · 3% margin
  • ₹10,000Paid-up capital
  • 16Employees (provident fund records)
  • +51%Revenue CAGR, 3 years
  • +49%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aldrin Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Aldrin Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Aldrin Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aldrin Pharma

Aldrin Pharma has 16 employees.

The primary company behind Aldrin Pharma, Aldrin Pharma Private Limited, reported revenue of β‚Ή3.91 Cr for FY 2024, up 40% year on year.

Aldrin Pharma Private Limited was incorporated on 7 April 2017 under the Companies Act 1956 and is recognized as a growing Indian healthcare company. A wide range of products, such as tablets, capsules, syrups, ointments, lotions, suspensions, and sachets, are marketed by the company to cater to various healthcare needs. Emphasis is placed on quality assurance, incorporation of latest research, and achievement of customer satisfaction through diverse business verticals. Contact information and testimonials indicate reliable operations from its base in Navi Mumbai.

Aldrin Pharma offers Tablets/Capsules and Syrup.

Aldrin Pharma operates through Aldrin Pharma Private Limited.

The legal entities of Aldrin Pharma currently have 4 directors, including Vasant Govind Gawate, Surekha Nitin Bankar, Neeta Santosh Adsul and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available